Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.480
+0.020 (0.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Eledon Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -45.62 | -36.18 | -116.54 | -87.97 | -34.51 | |
| Depreciation & Amortization | - | 0.36 | 0.37 | 0.37 | 0.2 | |
| Asset Writedown & Restructuring Costs | - | - | - | 48.65 | - | |
| Loss (Gain) From Sale of Investments | -1.7 | -2.8 | -1.2 | - | - | |
| Stock-Based Compensation | 10.45 | 13.12 | 6.55 | 8.15 | 7.9 | |
| Other Operating Activities | -33.13 | -30.48 | 76.21 | - | -2.35 | |
| Change in Accounts Payable | 6.72 | 7.75 | -2.6 | 2.08 | 2.14 | |
| Change in Other Net Operating Assets | 0.93 | 0.96 | -2.32 | 0.29 | -2.3 | |
| Operating Cash Flow | -62.34 | -47.27 | -39.53 | -28.42 | -28.91 | |
| Investment in Securities | 10.79 | -70.31 | -45.29 | - | - | |
| Investing Cash Flow | 10.79 | -70.31 | -45.29 | - | - | |
| Issuance of Common Stock | 53.81 | 133.52 | 33.02 | - | 0 | |
| Other Financing Activities | - | - | - | - | -0.45 | |
| Financing Cash Flow | 53.81 | 133.52 | 33.02 | - | -0.45 | |
| Net Cash Flow | 2.26 | 15.94 | -51.8 | -28.42 | -29.36 | |
| Free Cash Flow | -62.34 | -47.27 | -39.53 | -28.42 | -28.91 | |
| Free Cash Flow Per Share | -0.76 | -0.97 | -1.61 | -1.99 | -1.95 | |
| Levered Free Cash Flow | -33.66 | -21.4 | -24.47 | -13.85 | -15.33 | |
| Unlevered Free Cash Flow | -33.66 | -21.4 | -24.47 | -13.85 | -15.33 | |
| Change in Working Capital | 7.65 | 8.71 | -4.92 | 2.37 | -0.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.